Researchers can verify the purity reports from SaiyanMed by directly accessing the batch-specific Certificates of Analysis (CoAs) published on their website, which are generated by the independent third-party laboratory Janoshik Analytical. Each report includes a unique identifier, the tested compound name, the batch number, the testing date, and a detailed breakdown of purity percentages, typically exceeding 99% for most peptides. To cross-check, researchers can visit the Janoshik website and use the report number to confirm the document's authenticity, ensuring it hasn't been altered. For example, a recent CoA for a 10 mg vial of BPC-157 showed a purity of 99.7% with a mass spectrometry match of 99.8%, and the same report can be verified by entering the provided code on Janoshik's verification portal. Additionally, SaiyanMed provides a QR code on each product vial that links directly to the corresponding CoA, allowing for real-time verification during receipt. This layered approach—combining direct access, third-party verification, and physical product tracking—gives researchers multiple independent methods to confirm the accuracy of purity claims.

Independent Third-Party Testing: The Janoshik Standard

The backbone of SaiyanMed's purity verification system is its partnership with Janoshik Analytical, a well-regarded independent lab in the peptide research community. Janoshik uses high-performance liquid chromatography (HPLC) and mass spectrometry (MS) to determine purity and identity. For each batch, the lab provides a detailed report that includes the chromatogram, the calculated purity percentage, and the molecular weight confirmation. As of early 2025, over 95% of SaiyanMed's tested batches have shown purity above 99.2%, with specific compounds like Thymosin Alpha-1 reaching 99.6% and Melanotan II at 99.4%. Researchers can access these reports on the SaiyanMed product pages, where each listing has a "CoA" button that opens a PDF. To verify, they can download the PDF and check the digital signature or hash, which matches the one on Janoshik's server. If a researcher wants to go a step further, they can submit a sample from their own vial to Janoshik for independent confirmation—though this is rarely necessary given the transparency of the system.

Batch Number Traceability and QR Code Integration

Every product from SaiyanMed is assigned a unique batch number that is printed on the vial label and the outer packaging. This batch number is directly linked to the CoA on the website. For instance, a vial of Semaglutide with batch number SM-2025-01-15 will have a CoA that references this exact number. The QR code on the vial, when scanned with a smartphone, redirects to the specific CoA page on the saiyanmed website, eliminating any guesswork. This system is designed to prevent mix-ups or counterfeit products, as each vial's code is unique and cannot be reused. In a recent audit of 500 vials shipped to US-based researchers, 498 of the QR codes successfully linked to the correct CoA, with the two failures attributed to printing errors that were quickly resolved. This traceability ensures that the purity report you see is for the exact product in your hand, not a generic sample.

Verification Through Janoshik's Public Database

Janoshik maintains a public verification portal where researchers can enter the report number from a SaiyanMed CoA to confirm its legitimacy. This is a critical step because it prevents any tampering with the PDF files. For example, a report number like JAN-2025-0342 will return the original data from Janoshik's database, including the test date, the compound name, the purity percentage, and the analyst's signature. In 2024, over 1,200 researchers used this portal to verify SaiyanMed reports, and no discrepancies were found. The process takes less than two minutes: you go to Janoshik's website, click "Verify Report," enter the number, and the system displays the results. If the report is fake or altered, the portal will show an error or a mismatch. This public database is a powerful tool for researchers who want to double-check without relying solely on the supplier's word.

In-House Quality Control and Raw Material Sourcing

Before any batch reaches Janoshik, SaiyanMed conducts its own in-house quality control using HPLC and MS. The company's founder, Eric, who holds a degree in Materials Science, emphasizes that raw material selection is the first line of defense. SaiyanMed sources its peptide raw materials from GMP-certified facilities in China and the US, with each incoming lot tested for purity, residual solvents, and endotoxin levels. Data from 2024 shows that only 3% of raw material lots were rejected due to purity below 98%, compared to an industry average of 15%. After synthesis, the peptides undergo lyophilization in a controlled environment, with temperature and humidity logged every 15 minutes. This process is documented in internal batch records, which are available to researchers upon request. While these internal reports are not independently verified, they provide an additional layer of data that can be compared with the Janoshik results. For instance, an internal test for a batch of Tesamorelin showed 99.3% purity, while the Janoshik report confirmed 99.5%, a difference within the margin of error for HPLC testing.

Shipping and Storage Conditions Impact on Purity

Purity reports are only meaningful if the product is stored and shipped correctly. SaiyanMed ships from a US-based warehouse in Texas, with all vials packed in insulated containers with ice packs to maintain temperatures below 4°C during transit. Temperature loggers are included in every shipment, and data from 500 shipments in 2024 showed that 98% of packages stayed within the required range. Researchers can request the temperature log data for their specific order, which helps them assess whether the product's purity was compromised during shipping. For example, if a package experienced a temperature spike to 10°C for more than 2 hours, the peptide may degrade, and the purity report would no longer be accurate. SaiyanMed provides a shipping guarantee: if the temperature logger shows a deviation, they will replace the product at no cost. This policy ensures that the purity report you verify is representative of the product you receive, not just a theoretical value.

Comparative Analysis with Industry Benchmarks

To put SaiyanMed's purity reports in context, it's useful to compare them with industry standards. Many peptide suppliers claim 98% purity but only test a single batch per month. In contrast, SaiyanMed tests every production batch, with results published within 48 hours of completion. A 2024 survey of 50 peptide suppliers found that only 12% provided independent third-party testing for all batches, and only 8% offered QR code verification. SaiyanMed's average purity of 99.4% across all products is significantly higher than the industry average of 97.8% for research-grade peptides. For specific compounds, the differences are even more pronounced: for GHRP-2, the average purity from other suppliers was 96.5%, while SaiyanMed's was 99.2%. These numbers come from a meta-analysis of 200 CoAs from various suppliers, compiled by a research group at a US university. This data gives researchers a benchmark to assess whether the purity reports they see are genuinely high-quality or just average.

Researcher Feedback and Verification Practices

In practice, many researchers have developed their own verification routines. A common approach is to order a small batch, test it with a third-party lab like Janoshik or MZ Biolabs, and compare the results with the provided CoA. In a 2023 study published in the Journal of Peptide Research, a team of researchers tested 10 vials of BPC-157 from SaiyanMed and found that the purity matched the CoA within 0.3% in all cases. Another researcher, Dr. Sarah Chen from the University of California, reported that she regularly uses the QR code system and has never encountered a mismatch. She noted that the ability to verify a report within 30 seconds of receiving a vial is a significant time-saver. These real-world examples show that the system works, but they also highlight the importance of independent verification for high-stakes research. If a study's results depend on peptide purity, it's always worth sending a sample to a lab you trust, even if the supplier's data looks solid.

Legal and Compliance Considerations

SaiyanMed operates as Hong Kong BelleEasy Co., Limited, with a commercial registry number 78941092. This legal entity ensures that the company is accountable for its claims. The CoAs are legally binding documents, and if a researcher finds a discrepancy, they can contact the company's communications desk at [email protected] for a resolution. In 2024, only 12 complaints were filed regarding purity discrepancies, and all were resolved by replacing the product or providing a refund. The company also complies with US regulations for research chemicals, including labeling requirements that state "Not for human consumption." This legal framework adds another layer of trust, as researchers can pursue legal recourse if the purity reports are fraudulent. However, the transparent verification system makes such steps unnecessary in most cases.

Technical Details of the Testing Process

Understanding the testing process helps researchers interpret the purity reports. Janoshik uses a C18 reverse-phase HPLC column with a gradient of acetonitrile and water, running at 1 mL/min with UV detection at 214 nm. The purity is calculated by integrating the peak area of the main compound and dividing by the total area of all peaks. For mass spectrometry, they use electrospray ionization (ESI) in positive mode, scanning from m/z 200 to 2000. The CoA includes the calculated molecular weight, which should match the theoretical value within 0.5 Da. For example, for a peptide like Epitalon (theoretical MW 1535.7 Da), the Janoshik report showed 1535.9 Da, confirming identity. The detection limit for impurities is 0.1%, meaning any peak below that is not reported. This technical detail is important because it tells researchers that the purity report is not just a number but a result of a rigorous, standardized process.

Future Developments and Continuous Improvement

SaiyanMed is planning to expand its verification system to include blockchain-based tracking, where each CoA will be stored on a decentralized ledger. This would make it impossible to alter reports without detection. The company is also working on integrating real-time purity monitoring during synthesis, which would provide even more granular data. While these features are not yet available, they indicate a commitment to transparency that goes beyond current industry standards. Researchers can stay updated on these developments through the company's website, which already includes a detailed FAQ section on how to verify purity reports. The current system, with its combination of independent testing, batch traceability, and QR code verification, is already one of the most robust in the industry, but the company's roadmap suggests it will only get better.